dosage adjustment in renal and hepatic failure for medical student

DOSAGE ADJUSTMENT IN RENAL FAILURE
AND HEPATIC FAILURE
DEVSTHALI VIDYAPEETH COLLEGE OF PHARMACY
(Affiliated to Uttrakhand Technical University, Dehradun)
RUDRAPUR
PRESENTED TO:
MR. MANOJ BHARADWAJ
(ASSOCIATE PROFESSOR)
PRESENTED BY:
DEEPA JOSHI
B. PHARM
4TH YEAR
deepajoshi11.11dj@gmail.com
OVERVIEW
 Dose adjustment in Renal Failure
 Basics of kidney
 Common cause of kidney failure
 Dose adjustment based on drug clearance
 Identification of RENAL FUNCTION
• Criteria
• Inulin
• Creatinine
• Blood Urea Nitrogen
 Dose adjustment in Hepatic Failure
 Basic of liver
 Causes of hepatic failure
 Dosage adjustment in patient with hepatic impairment
 Liver Function Test
 Hepatic metabolism markers
BASICS OF KIDNEY
Kidney is the important organ for elimination of drug by mechanism of
GFR(Glomerulus filtration rate) & active tubular secretion & In normal case the
GFR rate is 120 ml/min.
Some chemical moieties is used for the identification of renal function.
Example: Inulin, Creatinine or some other marker.
RENAL FAILURE:
Renal failure or kidney failure describes a medical condition in which the kidney
fail to adequately filter toxins and waste products from the blood.
Renal failure is described as a decrease in glomerulus filtration rate(GFR).
Impairment of kidney function affects the pharmacokinetics of the drugs.
1
CAUSES OF RENAL FAILURE
Condition Comment
Hypertension Chronic overloading of kidney with fluid and
electrolytes lead to kidney insufficiency.
Diabetes mellitus The disturbance of sugar metabolism may lead to
degenerative renal disease.
Nephrotoxic drugs Certain drugs like aminoglycosides,
Phenacetin cause irreversible kidney disease.
Hypovolemia Any condition that causes a reduction in renal
blood leads to renal damage.
2
DOSE ADJUSTMENT BASED ON DRUG CLEARANCE
This method assume that the required therapeutic plasma drug concentration
in uremic patients is similar to that required in patients with normal renal
function.
3
IDENTIFICATION OF RENAL FUNCTION:
For the identification of renal function we used following method:
1. Inulin
2. Creatinine
3. Blood Urea Nitrogen(BUN)
Inulin : Inulin is a fructose polysaccharide fulfil most of criteria listed for markers.
 Markers should be water soluble & non toxic.
 Not bind to cell or protein.
 Markers should be filtered through glomerulus filtration.
 Should not be metabolise.
Creatinine: The creatinine is an endogenous substance form from creatinine
phosphate by muscle metabolism.
Creatinine concentration in blood depends on many physiological factors like –
muscle mass, body weight, age.
4
Blood Urea Nitrogen: The measurement of BUN is commonly used for diagnostic
test for the renal function.
The kidney failure increased the rate BUN, because urea is the end product of
metabolism of protein in body. The BUN level is 10-20mg/dl.
LIVER
Liver is the large glandular organ , involved in many metabolic processes.As it
does so, liver secretes bile that ends up back in the intestines.
LIVER FAILURE:
Liver failure is the inability of the liver to perform its normal synthetic and
metabolic function as part of normal physiology.
Causes of liver failure:
The liver can be damaged in a variety of ways:
 Cells can become inflamed (such as hepatitis).
 Bile flow can be obstructed(such as cholestasis).
 Cholesterol or triglycerides can accumulate (steatosis).
5
DOSAGE ADJUSTMENT IN PATIENT WITH
HEPATIC IMPAIRMENT
Case 1: If the metabolism of drug is 20%.
Case 2: The drug is gaseous and voletile in nature because excretion of drug through
lungs.
Liver function tests and hepatic metabolic markers
Liver function :
 Synthesis and storage of amino acids, proteins, vitamins and fats.
 Blood glucose level
 Blood circulation and filtration.
Liver function test:
1. Amino transferase method
2. Alkaline phosphate method
3. Bilirubin
4. Prothrombin time
6
HEPATIC METABOLIC MARKERS:
1.Aminotransferase method(AST) : AST value for males : 10-55U/L &
For females : 7-30 U/L.
2.Alkaline phosphatase(AT) : AP value for male : 45-115U/L &
For females : 30-100 U/L.
3.Bilirubin : Normal range : 0-1 mg/ml.
4.Prothrombin time: With the exception of factor 8, all coagulation factors are
synthesized by the liver, therefore hepatic disease can alter the coagulation.
Normal range is 11.2- 13.2 second.
7
dosage adjustment in renal and hepatic failure for medical student
1 sur 10

Recommandé

DRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASES par
DRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASESDRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASES
DRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASESDr.Amreen Saba Attariya
16.7K vues74 diapositives
Population pharmacokinetics par
Population pharmacokineticsPopulation pharmacokinetics
Population pharmacokineticsDr. Ramesh Bhandari
10.1K vues39 diapositives
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen par
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimenconversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimenpavithra vinayak
7.9K vues22 diapositives
Drug dose adjustment for liver diseases par
Drug dose adjustment  for liver diseasesDrug dose adjustment  for liver diseases
Drug dose adjustment for liver diseasesNeha Suresh
1.1K vues10 diapositives
Pharmacokinetic changes in renal impairment and dosage considerations par
Pharmacokinetic changes in renal impairment and dosage considerationsPharmacokinetic changes in renal impairment and dosage considerations
Pharmacokinetic changes in renal impairment and dosage considerationsDr Htet
10.7K vues19 diapositives
Effects of liver diseases on pharmacokinetics par
Effects of liver diseases on pharmacokineticsEffects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokineticsDr. Ramesh Bhandari
2.1K vues23 diapositives

Contenu connexe

Tendances

Therapeutic drug monitoring (TDM) of drugs used in seizure disorders par
Therapeutic drug monitoring (TDM) of drugs used in seizure disordersTherapeutic drug monitoring (TDM) of drugs used in seizure disorders
Therapeutic drug monitoring (TDM) of drugs used in seizure disordersAbel C. Mathew
10.2K vues34 diapositives
Effects of Liver disease on Pharmacokinetics par
Effects of Liver disease on Pharmacokinetics Effects of Liver disease on Pharmacokinetics
Effects of Liver disease on Pharmacokinetics Areej Abu Hanieh
12.1K vues25 diapositives
Tdm of cardiovascual drugs par
Tdm of cardiovascual drugsTdm of cardiovascual drugs
Tdm of cardiovascual drugsSenthilraj93
9.7K vues19 diapositives
Therapeutic drug monitoring of organ transplantation drugs par
Therapeutic drug monitoring of organ transplantation drugsTherapeutic drug monitoring of organ transplantation drugs
Therapeutic drug monitoring of organ transplantation drugsDr. Ramesh Bhandari
1.7K vues14 diapositives
Genetic polymorphism in drug transport and drug targets. par
Genetic polymorphism in drug transport and drug targets.Genetic polymorphism in drug transport and drug targets.
Genetic polymorphism in drug transport and drug targets.pavithra vinayak
5.4K vues24 diapositives
Dose adjustment in renal disease par
Dose adjustment in renal diseaseDose adjustment in renal disease
Dose adjustment in renal diseaseAreej Abu Hanieh
36.8K vues64 diapositives

Tendances(20)

Therapeutic drug monitoring (TDM) of drugs used in seizure disorders par Abel C. Mathew
Therapeutic drug monitoring (TDM) of drugs used in seizure disordersTherapeutic drug monitoring (TDM) of drugs used in seizure disorders
Therapeutic drug monitoring (TDM) of drugs used in seizure disorders
Abel C. Mathew10.2K vues
Effects of Liver disease on Pharmacokinetics par Areej Abu Hanieh
Effects of Liver disease on Pharmacokinetics Effects of Liver disease on Pharmacokinetics
Effects of Liver disease on Pharmacokinetics
Areej Abu Hanieh12.1K vues
Tdm of cardiovascual drugs par Senthilraj93
Tdm of cardiovascual drugsTdm of cardiovascual drugs
Tdm of cardiovascual drugs
Senthilraj939.7K vues
Therapeutic drug monitoring of organ transplantation drugs par Dr. Ramesh Bhandari
Therapeutic drug monitoring of organ transplantation drugsTherapeutic drug monitoring of organ transplantation drugs
Therapeutic drug monitoring of organ transplantation drugs
Genetic polymorphism in drug transport and drug targets. par pavithra vinayak
Genetic polymorphism in drug transport and drug targets.Genetic polymorphism in drug transport and drug targets.
Genetic polymorphism in drug transport and drug targets.
pavithra vinayak5.4K vues
Dose Adjustment in renal and hepatic failure par Pallavi Kurra
Dose Adjustment in renal and hepatic failureDose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failure
Pallavi Kurra70K vues
Genetic polymorphism in drug metabolism par Dr. Ankit Gaur
Genetic polymorphism in drug metabolismGenetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolism
Dr. Ankit Gaur10.4K vues
Pharmacokinetic changes of drugs in hepatic diseases par Dr Htet
Pharmacokinetic changes of drugs in hepatic diseasesPharmacokinetic changes of drugs in hepatic diseases
Pharmacokinetic changes of drugs in hepatic diseases
Dr Htet9.4K vues
Drug use in hepatic and renal impairment par Akshil Mehta
Drug use in hepatic and renal impairmentDrug use in hepatic and renal impairment
Drug use in hepatic and renal impairment
Akshil Mehta10.4K vues

Similaire à dosage adjustment in renal and hepatic failure for medical student

Pharmakokinetic Variations in Kidney diseases. par
Pharmakokinetic Variations in Kidney diseases.Pharmakokinetic Variations in Kidney diseases.
Pharmakokinetic Variations in Kidney diseases.Maleha Sial
409 vues31 diapositives
Effect of Liver Disease on Drug Metabolism par
Effect of Liver Disease on Drug Metabolism Effect of Liver Disease on Drug Metabolism
Effect of Liver Disease on Drug Metabolism Mariam Alosfoor
8.9K vues25 diapositives
LFT par
LFTLFT
LFTAjay Agade
2.8K vues9 diapositives
Liver Function Tests and their Interpretation.pdf par
Liver Function Tests and their Interpretation.pdfLiver Function Tests and their Interpretation.pdf
Liver Function Tests and their Interpretation.pdfssuser6dbad41
28 vues9 diapositives

Similaire à dosage adjustment in renal and hepatic failure for medical student(20)

Pharmakokinetic Variations in Kidney diseases. par Maleha Sial
Pharmakokinetic Variations in Kidney diseases.Pharmakokinetic Variations in Kidney diseases.
Pharmakokinetic Variations in Kidney diseases.
Maleha Sial409 vues
Effect of Liver Disease on Drug Metabolism par Mariam Alosfoor
Effect of Liver Disease on Drug Metabolism Effect of Liver Disease on Drug Metabolism
Effect of Liver Disease on Drug Metabolism
Mariam Alosfoor8.9K vues
Liver Function Tests and their Interpretation.pdf par ssuser6dbad41
Liver Function Tests and their Interpretation.pdfLiver Function Tests and their Interpretation.pdf
Liver Function Tests and their Interpretation.pdf
ssuser6dbad4128 vues
Renal function test par apeksha40
Renal function testRenal function test
Renal function test
apeksha401.1K vues
35 effects of renal disease on pharmacokinetics par Dang Thanh Tuan
35 effects of renal disease on pharmacokinetics35 effects of renal disease on pharmacokinetics
35 effects of renal disease on pharmacokinetics
Dang Thanh Tuan11.6K vues
Liver Function Tests and their Interpretation par dbpublications
Liver Function Tests and their InterpretationLiver Function Tests and their Interpretation
Liver Function Tests and their Interpretation
dbpublications154 vues
A Study on Diagnostic Importance of Serum Cholinesterase Activity in Hepatic.pdf par azhari80
A Study on Diagnostic Importance of Serum Cholinesterase Activity in Hepatic.pdfA Study on Diagnostic Importance of Serum Cholinesterase Activity in Hepatic.pdf
A Study on Diagnostic Importance of Serum Cholinesterase Activity in Hepatic.pdf
azhari807 vues

Dernier

LMLR 2023 Back and Joint Pain at 50 par
LMLR 2023 Back and Joint Pain at 50LMLR 2023 Back and Joint Pain at 50
LMLR 2023 Back and Joint Pain at 50Allan Corpuz
323 vues77 diapositives
NMP-5.pptx par
NMP-5.pptxNMP-5.pptx
NMP-5.pptxSai Sailesh Kumar Goothy
23 vues43 diapositives
Virtual Healing: Transforming Healthcare Worker Wellness Through VR par
Virtual Healing: Transforming Healthcare Worker Wellness Through VRVirtual Healing: Transforming Healthcare Worker Wellness Through VR
Virtual Healing: Transforming Healthcare Worker Wellness Through VRBadalona Serveis Assistencials
14 vues22 diapositives
Epileptogenesis par
EpileptogenesisEpileptogenesis
EpileptogenesisVamsi Krishna Koneru
8 vues50 diapositives
treatment of oropharyngeal cancer.pptx par
treatment of oropharyngeal cancer.pptxtreatment of oropharyngeal cancer.pptx
treatment of oropharyngeal cancer.pptxWoldemariam Beka
8 vues53 diapositives
melani glossophobia.pdf par
melani glossophobia.pdfmelani glossophobia.pdf
melani glossophobia.pdfPaygeon
9 vues1 diapositive

Dernier(20)

LMLR 2023 Back and Joint Pain at 50 par Allan Corpuz
LMLR 2023 Back and Joint Pain at 50LMLR 2023 Back and Joint Pain at 50
LMLR 2023 Back and Joint Pain at 50
Allan Corpuz323 vues
melani glossophobia.pdf par Paygeon
melani glossophobia.pdfmelani glossophobia.pdf
melani glossophobia.pdf
Paygeon9 vues
Structural Racism and Public Health: How to Talk to Policymakers and Communit... par katiequigley33
Structural Racism and Public Health: How to Talk to Policymakers and Communit...Structural Racism and Public Health: How to Talk to Policymakers and Communit...
Structural Racism and Public Health: How to Talk to Policymakers and Communit...
katiequigley33290 vues
Subdural hemorrhage Acute, Chronic & Spontaneous by momen par Momen Ali Khan
Subdural hemorrhage Acute, Chronic & Spontaneous by momenSubdural hemorrhage Acute, Chronic & Spontaneous by momen
Subdural hemorrhage Acute, Chronic & Spontaneous by momen
Momen Ali Khan14 vues
pericardium and heart topography with dr. Ameera Al-Humidi.pptx par Ameera Al-Humidi
pericardium and heart topography with dr. Ameera Al-Humidi.pptxpericardium and heart topography with dr. Ameera Al-Humidi.pptx
pericardium and heart topography with dr. Ameera Al-Humidi.pptx
Work role & Dynamic Responsibilities of Radiation Therapists & PTV Margin Con... par Subrata Roy
Work role & Dynamic Responsibilities of Radiation Therapists & PTV Margin Con...Work role & Dynamic Responsibilities of Radiation Therapists & PTV Margin Con...
Work role & Dynamic Responsibilities of Radiation Therapists & PTV Margin Con...
Subrata Roy149 vues
BUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docx par InkhaRina
BUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docxBUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docx
BUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docx
InkhaRina28 vues
Top PCD Pharma Franchise Companies in India | Saphnix Lifesciences par Saphnix Lifesciences
Top PCD Pharma Franchise Companies in India | Saphnix LifesciencesTop PCD Pharma Franchise Companies in India | Saphnix Lifesciences
Top PCD Pharma Franchise Companies in India | Saphnix Lifesciences
Cholera Romy W. (3).pptx par rweth613
Cholera Romy W. (3).pptxCholera Romy W. (3).pptx
Cholera Romy W. (3).pptx
rweth61330 vues
Preparation and Evaluation Ointment.pptx par Sudhanshu Sagar
Preparation and Evaluation Ointment.pptxPreparation and Evaluation Ointment.pptx
Preparation and Evaluation Ointment.pptx
Sudhanshu Sagar51 vues
Lifestyle Measures to Prevent Brain Diseases.pptx par Sudhir Kumar
Lifestyle Measures to Prevent Brain Diseases.pptxLifestyle Measures to Prevent Brain Diseases.pptx
Lifestyle Measures to Prevent Brain Diseases.pptx
Sudhir Kumar618 vues

dosage adjustment in renal and hepatic failure for medical student

  • 1. DOSAGE ADJUSTMENT IN RENAL FAILURE AND HEPATIC FAILURE DEVSTHALI VIDYAPEETH COLLEGE OF PHARMACY (Affiliated to Uttrakhand Technical University, Dehradun) RUDRAPUR PRESENTED TO: MR. MANOJ BHARADWAJ (ASSOCIATE PROFESSOR) PRESENTED BY: DEEPA JOSHI B. PHARM 4TH YEAR deepajoshi11.11dj@gmail.com
  • 2. OVERVIEW  Dose adjustment in Renal Failure  Basics of kidney  Common cause of kidney failure  Dose adjustment based on drug clearance  Identification of RENAL FUNCTION • Criteria • Inulin • Creatinine • Blood Urea Nitrogen  Dose adjustment in Hepatic Failure  Basic of liver  Causes of hepatic failure  Dosage adjustment in patient with hepatic impairment  Liver Function Test  Hepatic metabolism markers
  • 3. BASICS OF KIDNEY Kidney is the important organ for elimination of drug by mechanism of GFR(Glomerulus filtration rate) & active tubular secretion & In normal case the GFR rate is 120 ml/min. Some chemical moieties is used for the identification of renal function. Example: Inulin, Creatinine or some other marker. RENAL FAILURE: Renal failure or kidney failure describes a medical condition in which the kidney fail to adequately filter toxins and waste products from the blood. Renal failure is described as a decrease in glomerulus filtration rate(GFR). Impairment of kidney function affects the pharmacokinetics of the drugs. 1
  • 4. CAUSES OF RENAL FAILURE Condition Comment Hypertension Chronic overloading of kidney with fluid and electrolytes lead to kidney insufficiency. Diabetes mellitus The disturbance of sugar metabolism may lead to degenerative renal disease. Nephrotoxic drugs Certain drugs like aminoglycosides, Phenacetin cause irreversible kidney disease. Hypovolemia Any condition that causes a reduction in renal blood leads to renal damage. 2
  • 5. DOSE ADJUSTMENT BASED ON DRUG CLEARANCE This method assume that the required therapeutic plasma drug concentration in uremic patients is similar to that required in patients with normal renal function. 3
  • 6. IDENTIFICATION OF RENAL FUNCTION: For the identification of renal function we used following method: 1. Inulin 2. Creatinine 3. Blood Urea Nitrogen(BUN) Inulin : Inulin is a fructose polysaccharide fulfil most of criteria listed for markers.  Markers should be water soluble & non toxic.  Not bind to cell or protein.  Markers should be filtered through glomerulus filtration.  Should not be metabolise. Creatinine: The creatinine is an endogenous substance form from creatinine phosphate by muscle metabolism. Creatinine concentration in blood depends on many physiological factors like – muscle mass, body weight, age. 4
  • 7. Blood Urea Nitrogen: The measurement of BUN is commonly used for diagnostic test for the renal function. The kidney failure increased the rate BUN, because urea is the end product of metabolism of protein in body. The BUN level is 10-20mg/dl. LIVER Liver is the large glandular organ , involved in many metabolic processes.As it does so, liver secretes bile that ends up back in the intestines. LIVER FAILURE: Liver failure is the inability of the liver to perform its normal synthetic and metabolic function as part of normal physiology. Causes of liver failure: The liver can be damaged in a variety of ways:  Cells can become inflamed (such as hepatitis).  Bile flow can be obstructed(such as cholestasis).  Cholesterol or triglycerides can accumulate (steatosis). 5
  • 8. DOSAGE ADJUSTMENT IN PATIENT WITH HEPATIC IMPAIRMENT Case 1: If the metabolism of drug is 20%. Case 2: The drug is gaseous and voletile in nature because excretion of drug through lungs. Liver function tests and hepatic metabolic markers Liver function :  Synthesis and storage of amino acids, proteins, vitamins and fats.  Blood glucose level  Blood circulation and filtration. Liver function test: 1. Amino transferase method 2. Alkaline phosphate method 3. Bilirubin 4. Prothrombin time 6
  • 9. HEPATIC METABOLIC MARKERS: 1.Aminotransferase method(AST) : AST value for males : 10-55U/L & For females : 7-30 U/L. 2.Alkaline phosphatase(AT) : AP value for male : 45-115U/L & For females : 30-100 U/L. 3.Bilirubin : Normal range : 0-1 mg/ml. 4.Prothrombin time: With the exception of factor 8, all coagulation factors are synthesized by the liver, therefore hepatic disease can alter the coagulation. Normal range is 11.2- 13.2 second. 7